C-Rad Yönetim

Yönetim kriter kontrolleri 1/4

C-Rad CEO'su Cecilia de Leeuw, Dec2022 tarihinde atandı, in görev süresi 1.92 yıldır. in toplam yıllık tazminatı SEK 2.98M olup, şirket hissesi ve opsiyonları dahil olmak üzere 70.4% maaş ve 29.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.042% ine doğrudan sahiptir ve bu hisseler SEK 399.67K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.9 yıl ve 1.5 yıldır.

Anahtar bilgiler

Cecilia de Leeuw

İcra Kurulu Başkanı

SEK 3.0m

Toplam tazminat

CEO maaş yüzdesi	70.4%
CEO görev süresi	1.9yrs
CEO sahipliği	0.04%
Yönetim ortalama görev süresi	1.9yrs
Yönetim Kurulu ortalama görev süresi	1.5yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Cecilia de Leeuw'un ücretlendirmesi C-Rad'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	SEK 58m
Jun 30 2024	n/a	n/a	SEK 54m
Mar 31 2024	n/a	n/a	SEK 48m
Dec 31 2023	SEK 3m	SEK 2m	SEK 36m
Sep 30 2023	n/a	n/a	SEK 24m
Jun 30 2023	n/a	n/a	SEK 20m
Mar 31 2023	n/a	n/a	SEK 12m
Dec 31 2022	SEK 839k	SEK 175k	SEK 7m

Tazminat ve Piyasa: Cecilia 'ın toplam tazminatı ($USD 271.12K ) UK pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 354.57K ).

Tazminat ve Kazançlar: Cecilia 'in maaşı son bir yılda %20'den fazla arttı.

CEO

Cecilia de Leeuw (56 yo)

1.9yrs

Görev süresi

SEK 2,981,000

Tazminat

Ms. Cecilia de Leeuw was Director of Kambi Group plc since May 16, 2019 until May 22, 2024. She is an Independent Director of Net Insight AB (publ) since May 2022. She is Chief Executive Officer of C-Rad A...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Cecilia de Leeuw	CEO & President	1.9yrs	SEK 2.98m	0.042% SEK 399.7k
Linda Frölén	Chief Financial Officer	less than a year	Veri yok	Veri yok
Hakan Axelsson	Chief Operating Officer	5.3yrs	Veri yok	Veri yok
Greta Cattani	Global Marketing Director	1.2yrs	Veri yok	Veri yok
Anna Aman	Human Resource Manager	less than a year	Veri yok	Veri yok
Xiaodong Wang	President of C-RAD China	6.8yrs	Veri yok	0.12% SEK 1.1m
Ivan Astralaga	President of C-RAD Americas	3.5yrs	Veri yok	Veri yok
Basak Karakus	Executive for Global Digital Marketing	no data	Veri yok	Veri yok

1.9yrs

Ortalama Görev Süresi

50.5yo

Ortalama Yaş

Deneyimli Yönetim: 0R44 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.9 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kristina Willgard	Independent Chair of the Board	1.5yrs	SEK 280.00k	0.030% SEK 285.5k
Mats Thoren	Independent Director	less than a year	Veri yok	Veri yok
Jenny Rosberg	Independent Director	3.8yrs	SEK 255.00k	0.051% SEK 485.4k
Susanne Ekblom	Independent Director	1.5yrs	SEK 160.00k	Veri yok
Peter Simonsbacka	Independent Director	1.5yrs	SEK 147.00k	Veri yok
David Sjostrom	Independent Director	7.5yrs	SEK 220.00k	Veri yok

1.5yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 0R44 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 1.5 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

C-Rad Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Independent Director recently bought kr190k worth of stock

CEO & President recently bought kr85k worth of stock

C-Rad AB (publ) Appoints Mats Thorén as Board Member

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

C-Rad AB (publ) to Report Q3, 2025 Results on Oct 23, 2025

Independent Director recently bought kr190k worth of stock

New minor risk - Market cap size

Third quarter 2024 earnings released: EPS: kr0.45 (vs kr0.32 in 3Q 2023)

CEO & President recently bought kr85k worth of stock

Second quarter 2024 earnings released: EPS: kr0.31 (vs kr0.16 in 2Q 2023)

Full year 2023 earnings released: EPS: kr1.05 (vs kr0.22 in FY 2022)

C-Rad AB (publ) Appoints Mats Thorén as Board Member

C-Rad AB (publ) to Report Fiscal Year 2023 Results on Apr 23, 2024

Full year 2023 earnings released: EPS: kr1.36 (vs kr0.22 in FY 2022)

C-Rad AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Third quarter 2023 earnings released

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

C-Rad AB (Publ) Announces Former Employee Appeals Verdict from the Patent and Market Court of Appeal

New major risk - Earnings quality

C-Rad AB (publ) to Demonstrate Enhancements in Surface Guided Solutions for Advanced Radiotherapy Treatments at AAPM

Second quarter 2023 earnings released

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

C-Rad AB (publ) to Report Fiscal Year 2022 Final Results on Apr 06, 2023

C-Rad AB (Publ) Appoints Christoffer Herou as CFO

C-Rad AB (Publ) Announces CEO Changes

C-Rad AB (publ) Announces CFO Changes

C-Rad AB (publ) to Report Q3, 2023 Results on Oct 27, 2023

C-RAD Launches New Updated eDucation Portal as an Online Platform

Second quarter 2022 earnings released

Henrik Bergentoft Resigns as CFO of C-RAD

C-Rad Announces CEO Changes

Insufficient new directors

Insufficient new directors

C-Rad AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

C-Rad Achieves Another Milestone Ensuring the Availability of SGRT, the Standard of Care for Radiotherapy

Third quarter 2021 earnings released

Chief Operating Officer recently sold kr625k worth of stock

Second quarter 2021 earnings released

C-Rad AB (publ) Announces The Patent and Market Court Rejected Former Employee Claim for Compensation

The Patent and Market Court of Appeal Issues Judgement Confirming C-Rad's Entitlement to Beamocular's Invention

Full year 2020 earnings released: EPS kr0.43 (vs kr0.45 loss in FY 2019)

C-RAD and Alliance Radiation Oncology Announce That Alliance Has Become the First Center in the Greater Northshore Area to Integrate C-Rad

C-Rad and With-Global Engages in a Partnership for the South Korean Market

C-RAD Receives Order for Proton Cancer Treatment Centers in the US

Shenzhen Proton Therapy Treatment Center Selects C-Rad Catalyst™ System

C-Rad AB (publ) to Report Q2, 2021 Results on Jul 29, 2021

Shanghai Proton and Heavy Ion Hospital Decides for C-Rad Sigrt Solution

Australian Customers Select C-RAD’s Cutting Edge SIGRT Solution

C-Rad AB Receives SEK 11 Million Order for Cutting Edge SIGRT Solution by DTZ in Berlin

Independent Director recently sold kr672.4k worth of stock

Independent Director recently bought kr1.7m worth of stock

Independent Director recently sold kr3.4m worth of stock

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş